153 related articles for article (PubMed ID: 27269234)
1. Adverse impact of intermittent portal clamping on long-term postoperative outcomes in hepatocellular carcinoma.
Hao S; Chen S; Yang X; Wan C
Ann R Coll Surg Engl; 2017 Jan; 99(1):22-27. PubMed ID: 27269234
[TBL] [Abstract][Full Text] [Related]
2. Impact of intermittent portal clamping on the early recurrence of hepatocellular carcinoma after surgery.
Hao S; Chen S; Yang X; Wan C
Surg Today; 2016 Nov; 46(11):1290-5. PubMed ID: 26935546
[TBL] [Abstract][Full Text] [Related]
3. Selective main portal vein clamping to minimize the risk of recurrence after curative liver resection for hepatocellular carcinoma.
Yang Y; Fu SY; Lau WY; Lai ECh; Li AJ; Pan ZY; Zhou WP; Shen F; Wu MC
Hepatogastroenterology; 2012; 59(117):1560-5. PubMed ID: 22683973
[TBL] [Abstract][Full Text] [Related]
4. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
5. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
6. Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score-matched survival analysis.
Gao Y; Wang PX; Cheng JW; Sun YF; Hu B; Guo W; Zhou KQ; Yin Y; Li YC; Wang J; Huang JF; Qiu SJ; Zhou J; Fan J; Yang XR
Cancer Med; 2019 Nov; 8(16):6933-6944. PubMed ID: 31566899
[TBL] [Abstract][Full Text] [Related]
7. Modified Child-Pugh grade
Huang F; Gao J
World J Gastroenterol; 2020 Feb; 26(7):749-758. PubMed ID: 32116422
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting the recurrence and survival of hepatocellular carcinoma after hepatectomy: a retrospective study of 601 Chinese patients.
Zhang TT; Zhao XQ; Liu Z; Mao ZY; Bai L
Clin Transl Oncol; 2016 Aug; 18(8):831-40. PubMed ID: 26577107
[TBL] [Abstract][Full Text] [Related]
10. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
[TBL] [Abstract][Full Text] [Related]
11. Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion.
Lee D; Lee HC; An J; Shim JH; Kim KM; Lim YS; Chung YH; Lee YS
Clin Mol Hepatol; 2018 Jun; 24(2):144-150. PubMed ID: 29665630
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy.
Huang J; Li BK; Chen GH; Li JQ; Zhang YQ; Li GH; Yuan YF
J Gastrointest Surg; 2009 Sep; 13(9):1627-35. PubMed ID: 19506976
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience.
Park SK; Jung YK; Chung DH; Kim KK; Park YH; Lee JN; Kwon OS; Kim YS; Choi DJ; Kim JH
Korean J Intern Med; 2013 Jul; 28(4):428-38. PubMed ID: 23864801
[TBL] [Abstract][Full Text] [Related]
14. Dynamic liver function is an independent predictor of recurrence-free survival after curative liver resection for HCC - A retrospective cohort study.
Blüthner E; Bednarsch J; Malinowski M; Binder P; Pratschke J; Stockmann M; Kaffarnik M
Int J Surg; 2019 Nov; 71():56-65. PubMed ID: 31494333
[TBL] [Abstract][Full Text] [Related]
15. Tumor size does not independently affect long-term survival after curative resection of solitary hepatocellular carcinoma without macroscopic vascular invasion.
Zhang H; Yuan SX; Dai SY; Zhang JM; Huang X; Lu CD; Lu JH; Wu FQ; Lau WY; Wu MC; Yang T; Shen F
World J Surg; 2014 Apr; 38(4):947-57. PubMed ID: 24258262
[TBL] [Abstract][Full Text] [Related]
16. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion.
Kim JM; Kwon CH; Joh JW; Ko JS; Park JB; Lee JH; Kim SJ; Paik SW; Park CK
World J Surg Oncol; 2013 Apr; 11():92. PubMed ID: 23618082
[TBL] [Abstract][Full Text] [Related]
18. Factors linked to longterm survival of patients with hepatocellular carcinoma accompanied by tumour thrombus in the major portal vein after surgical resection.
Matono R; Yoshiya S; Motomura T; Toshima T; Kayashima H; Masuda T; Yoshizumi T; Taketomi A; Shirabe K; Maehara Y
HPB (Oxford); 2012 Apr; 14(4):247-53. PubMed ID: 22404263
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma.
Kamiyama T; Nakanishi K; Yokoo H; Kamachi H; Tahara M; Kakisaka T; Tsuruga Y; Todo S; Taketomi A
World J Surg Oncol; 2012 Jun; 10():107. PubMed ID: 22697061
[TBL] [Abstract][Full Text] [Related]
20. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]